MoneyWorks4Me

The Sales for the quarter ended September 2024 of Rs. 27.06 million declined by -99.00% from Rs. 2703.00 millions.A big loss of -98.94% reported for the quarter ended September 2024 to Rs. 3.20  millions from Rs. 300.95 millions.A decline of 9.47 millions was observed in the OP in the quarter ended September 2024 from 707.96 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 27.06 2703.00 -99.00 331.62 5693.06 -94.18 12273.18 11519.57 6.54
Other Income 129.46 73.97 75.02 240.85 129.50 85.98 453.14 332.82 36.15
PBIDT 9.47 707.96 -98.66 75.54 1361.63 -94.45 2952.81 2553.74 15.63
Interest 4.11 211.38 -98.06 5.80 415.22 -98.60 510.96 921.66 -44.56
PBDT 5.36 496.58 -98.92 69.74 946.41 -92.63 6307.75 1365.60 361.90
Depreciation 2.16 131.88 -98.36 4.66 270.73 -98.28 533.03 573.62 -7.08
PBT 3.20 364.70 -99.12 65.08 675.68 -90.37 5774.72 791.98 629.15
TAX 0.00 63.75 0.00 0.00 204.24 0.00 1590.81 367.25 333.17
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -108.43 233.61 -146.41
PAT 3.20 300.95 -98.94 65.08 471.44 -86.20 4183.91 424.73 885.08
Equity 590.87 590.87 0.00 590.87 590.87 0.00 590.87 590.87 0.00
PBIDTM(%) 35.00 26.19 33.62 22.78 23.92 -4.76 24.06 22.17 8.53
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..